ArticleMaterials (Basel, Switzerland)2021
Pathways to Green Perspectives: Production and Characterization of Polylactide (PLA) Nanocomposites Filled with Superparamagnetic Magnetite Nanoparticles.
Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Tailoring the Properties of Magnetite/PLA Nanocomposites: A Composition-Dependent Study.Polymers · 2025Article
- Article
- Polymer Rheology and Processing of Nano- and Micro-Composites.Materials (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In the category of biopolymers, polylactide or polylactic acid (PLA) is one of the most promising candidates considered for future developments, as it is not only biodegradable under industrial composting conditions, but it is produced from renewable natural resources. The modification of PLA through the addition of nanofillers is considered as a modern approach to improve its main characteristic features (mechanical, thermal, barrier, etc.) and to obtain specific end-use properties. Iron oxide nanoparticles (NPs) of low dimension (10-20 nm) such as magnetite (Fe
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.